Little Green Pharma Ltd (LGP) - Net Assets
Based on the latest financial reports, Little Green Pharma Ltd (LGP) has net assets worth AU$86.02 Million AUD (≈ $60.86 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$97.60 Million ≈ $69.06 Million USD) and total liabilities (AU$11.59 Million ≈ $8.20 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check LGP financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$86.02 Million |
| % of Total Assets | 88.13% |
| Annual Growth Rate | 80.14% |
| 5-Year Change | -9.45% |
| 10-Year Change | N/A |
| Growth Volatility | 237.31 |
Little Green Pharma Ltd - Net Assets Trend (2017–2025)
This chart illustrates how Little Green Pharma Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Little Green Pharma Ltd asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Little Green Pharma Ltd (2017–2025)
The table below shows the annual net assets of Little Green Pharma Ltd from 2017 to 2025. For live valuation and market cap data, see Little Green Pharma Ltd market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$85.02 Million ≈ $60.15 Million |
+10.04% |
| 2024-06-30 | AU$77.26 Million ≈ $54.66 Million |
-6.05% |
| 2023-06-30 | AU$82.23 Million ≈ $58.18 Million |
+8.94% |
| 2022-06-30 | AU$75.48 Million ≈ $53.41 Million |
-19.61% |
| 2021-06-30 | AU$93.89 Million ≈ $66.43 Million |
+663.52% |
| 2020-06-30 | AU$12.30 Million ≈ $8.70 Million |
-12.62% |
| 2019-06-30 | AU$14.07 Million ≈ $9.96 Million |
+286.69% |
| 2018-06-30 | AU$3.64 Million ≈ $2.57 Million |
+374.71% |
| 2017-06-30 | AU$766.61K ≈ $542.42K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Little Green Pharma Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2869684600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$102.23 Million | 120.25% |
| Other Comprehensive Income | AU$11.70 Million | 13.76% |
| Total Equity | AU$85.02 Million | 100.00% |
Little Green Pharma Ltd Competitors by Market Cap
The table below lists competitors of Little Green Pharma Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Elevation Oncology Inc
NASDAQ:ELEV
|
$21.63 Million |
|
Archtis Ltd
AU:AR9
|
$21.63 Million |
|
Bannari Amman Spinning Mills Limited
NSE:BASML
|
$21.64 Million |
|
Chasys
KO:033250
|
$21.66 Million |
|
Rubean AG
F:R1B
|
$21.60 Million |
|
WhiteSmoke Software Ltd
TA:WSMK
|
$21.60 Million |
|
Nyesa Valores Corp SA
MC:NYE
|
$21.59 Million |
|
Beamtree Holdings Ltd
AU:BMT
|
$21.59 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Little Green Pharma Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 77,257,000 to 85,016,000, a change of 7,759,000 (10.0%).
- Net income of 3,324,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 11,702,000.
- Other factors decreased equity by 7,267,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$3.32 Million | +3.91% |
| Other Comprehensive Income | AU$11.70 Million | +13.76% |
| Other Changes | AU$-7.27 Million | -8.55% |
| Total Change | AU$- | 10.04% |
Book Value vs Market Value Analysis
This analysis compares Little Green Pharma Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.36x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 17.40x to 0.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | AU$0.01 | AU$0.10 | x |
| 2018-06-30 | AU$0.03 | AU$0.10 | x |
| 2019-06-30 | AU$0.11 | AU$0.10 | x |
| 2020-06-30 | AU$0.10 | AU$0.10 | x |
| 2021-06-30 | AU$0.57 | AU$0.10 | x |
| 2022-06-30 | AU$0.32 | AU$0.10 | x |
| 2023-06-30 | AU$0.33 | AU$0.10 | x |
| 2024-06-30 | AU$0.26 | AU$0.10 | x |
| 2025-06-30 | AU$0.28 | AU$0.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Little Green Pharma Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.91%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.03%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 1.13x
- Recent ROE (3.91%) is above the historical average (-32.50%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -28.33% | -84168.22% | 0.00x | 1.26x | AU$-293.81K |
| 2018 | -103.26% | -6901.78% | 0.01x | 1.11x | AU$-4.12 Million |
| 2019 | -39.21% | -2220.58% | 0.02x | 1.11x | AU$-6.93 Million |
| 2020 | -67.30% | -375.51% | 0.13x | 1.33x | AU$-9.51 Million |
| 2021 | -4.64% | -62.20% | 0.06x | 1.18x | AU$-13.75 Million |
| 2022 | -31.89% | -171.43% | 0.15x | 1.27x | AU$-31.62 Million |
| 2023 | -11.19% | -47.04% | 0.20x | 1.20x | AU$-17.43 Million |
| 2024 | -10.55% | -31.81% | 0.30x | 1.12x | AU$-15.88 Million |
| 2025 | 3.91% | 9.03% | 0.38x | 1.13x | AU$-5.18 Million |
Industry Comparison
This section compares Little Green Pharma Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $29,670,098
- Average return on equity (ROE) among peers: 4903.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Little Green Pharma Ltd (LGP) | AU$86.02 Million | -28.33% | 0.13x | $21.63 Million |
| Althea Group Holdings Ltd (AGH) | $41.45 Million | -29.25% | 0.36x | $12.05 Million |
| BOD Science Ltd (BOD) | $3.47 Million | -155.95% | 0.53x | $3.01 Million |
| BPH Global Ltd (BP8) | $149.84K | 50079.24% | 22.90x | $2.62 Million |
| Cann Group Ltd (CAN) | $648.33K | -644.19% | 0.12x | $5.62 Million |
| ECS Botanics Holdings Ltd (ECS) | $319.74K | -109.87% | 0.16x | $5.65 Million |
| Ecofibre Ltd (EOF) | $109.94 Million | -13.34% | 0.36x | $5.36 Million |
| Epsilon Healthcare Ltd (EPN) | $2.99 Million | -68.61% | 4.98x | $5.51 Million |
| Elixinol Wellness Ltd (EXL) | $99.42 Million | 0.00% | 0.04x | $2.05 Million |
| IDT Australia Ltd (IDT) | $32.86 Million | 21.64% | 0.29x | $12.10 Million |
| Invion Ltd (IVX) | $5.46 Million | -46.66% | 0.11x | $3.70 Million |
About Little Green Pharma Ltd
Little Green Pharma Ltd engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally. The company offers dried cannabis flower medicines and cannabis oils. Little Green Pharma Ltd was incorporated in 2016 and is based in West Perth, Australia.